←Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Brain Metastasis
Georgina Long
MD, PhD
🏢University of Sydney🌐Australia
Medical Director, Melanoma Institute Australia
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Georgina Long is a world leader in melanoma clinical trials including BRAF MEK inhibitor and checkpoint blockade strategies for brain metastases. Her work advances both targeted and immunotherapy approaches for CNS melanoma. She co leads the Melanoma Institute Australia.
Share:
🧪Research Fields 研究领域
melanoma
brain metastasis
BRAF MEK inhibitors
immunotherapy
neoadjuvant therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Georgina Long 的研究动态
Follow Georgina Long's research updates
留下邮箱,当我们发布与 Georgina Long(University of Sydney)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment